BMP2 and osteogenesis imperfecta: The utilization of multiple osteogenic inducing agents, including bone morphogenetic protein-2 (BMP-2) and Nell1, has been observed to yield favorable results in the treatment of OI (Cheng et al., 2019; Liu et al., 2020).